Medartis Holding (MDRS.F) Stock Overview
A medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
MDRS.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Medartis Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 115.00 |
| 52 Week High | CHF 115.00 |
| 52 Week Low | CHF 100.00 |
| Beta | 1.2 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 47.51% |
| 5 Year Change | n/a |
| Change since IPO | 140.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDRS.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -1.4% |
| 1Y | n/a | -21.8% | 16.4% |
Return vs Industry: Insufficient data to determine how MDRS.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MDRS.F performed against the US Market.
Price Volatility
| MDRS.F volatility | |
|---|---|
| MDRS.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: MDRS.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MDRS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,259 | Matthias Schupp | www.medartis.com |
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products.
Medartis Holding AG Fundamentals Summary
| MDRS.F fundamental statistics | |
|---|---|
| Market cap | US$1.24b |
| Earnings (TTM) | US$10.70m |
| Revenue (TTM) | US$345.01m |
Is MDRS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDRS.F income statement (TTM) | |
|---|---|
| Revenue | CHF 269.26m |
| Cost of Revenue | CHF 64.93m |
| Gross Profit | CHF 204.33m |
| Other Expenses | CHF 195.98m |
| Earnings | CHF 8.35m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 18, 2026
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 75.89% |
| Net Profit Margin | 3.10% |
| Debt/Equity Ratio | 47.3% |
How did MDRS.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/30 00:29 |
| End of Day Share Price | 2026/03/02 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medartis Holding AG is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Research Partners AG |
| Ilya Burgansky | Research Partners AG |
| Alexander Burgansky | Research Partners AG |